What we believe
As an organization committed to driving change in caring for patients with diabetes and other chronic diseases, we have a responsibility to make Diversity, Equity, Inclusion & Belonging (DEI&B) part of everything we do -- from developing our products to building and supporting our workforce.
Our commitment to DEI&B is in keeping with the Novo Nordisk
Way, which calls upon us to do all we can for the patients and
communities we serve, including our own Novo Nordisk employees, some
of whom are also patients and caregivers.
To innovate, we must be diverse. To enable diversity and thrive, we
must have equity. To activate diversity and equity, we must be
inclusive. To unlock our potential, we need belonging.
A disproportionate number of minority populations face health inequities, are affected by serious chronic diseases such as diabetes and obesity and are at increased risk for developing complications of these diseases and others.
Our long-standing commitment ranges from large-scale relationships with the American Diabetes Association and the National Hemophilia Foundation, to local efforts to educate patients about diabetes. Many of our efforts support minority and underserved communities, including:
Our commitment to ensure diverse representation in our clinical trials is a key priority of our patient-centered business approach. We have worked diligently to proactively include sites and Investigators in our trials that engage with diverse patient populations, while raising awareness of the opportunities for clinical trial partnership and participation. With a deliberate focus on developing and improving upon our patient-facing materials and resources, and leveraging patient insights, we continuously improve upon our trial design and operational strategies.
We will continue to reinforce a culture of diversity, equity, inclusion and belonging in clinical trials, expanding and evolving our areas of focus to identify and address barriers to clinical trial participation, including access, mistrust and health disparities – staying focused on and dedicated to our patients, providers and communities.
Our Supplier Diversity program helps us identify, contract with and develop small and minority owned businesses that reflect the patients we serve while ensuring the continuity of our business and compliance with federal regulations. We encourage all of our suppliers to show that they share our values by providing meaningful opportunities to small and diverse businesses.
Companies that are certified by a recognized/authorized third party organization or are self-certified, provide a commodity/service that Novo Nordisk purchases and have the capacity to meet our business needs, are invited to register with us.
Suppliers must complete and attach to their company profile, a Self-Certification Affadavit form, when completing the online registration.
Available for download here: Self-Certification Affadavit
Novo Nordisk has nine Employee Resource Groups (ERGs) that drive our efforts to foster a sense of belonging and build a more diverse, equitable, and inclusive workplace.
Open to all, these groups enhance the work experience and professional development of many of our employees, and ultimately help us to retain and recruit a more diverse workforce to better serve patients and communities.
We stand with the Human Rights Campaign in calling for the passage of the Equality Act, landmark legislation to help guarantee that all Americans have equal rights and live free of discrimination.
Change happens when we make it our responsibility to act.
This is the largest CEO-driven business commitment to advance diversity & inclusion within the workplace. Recognizing that change starts at the executive level, nearly 2,000 CEOs and Presidents of the world’s leading companies and business organizations are leveraging their individual and collective voices to advance diversity & inclusion in the workplace. By signing the pledge, this group of executives acknowledge the opportunity – and responsibility – to play a meaningful role in such an important societal issue.